Authors

• Gennady Bratslavsky (ORCID: https://orcid.org/0000-0002-2712-4375)
• S. Berg
• Naomi B. Haas (ORCID: https://orcid.org/0000-0001-8907-7968)
• Mehmet Asım Bilen (ORCID: https://orcid.org/0000-0003-4003-1103)
• Nabil Adra (ORCID: https://orcid.org/0000-0001-8905-8329)
• James O. Jones (ORCID: https://orcid.org/0000-0002-2194-4903)
• Se Eun Kim (ORCID: https://orcid.org/0000-0001-6626-0786)
• MA Carducci
• Sabina Signoretti
• James Blackmur
• Brian M. Shuch
• Yasser Ged
• Mohamad E. Allaf
• Viraj A. Master
• Dror Michaelson
• David F. McDermott
• Grant D. Stewart
• Daniel Yick Chin Heng
• Axel Bex
• Nirmish Singla

Institutions

• Indiana University Health (US)
• Brigham and Women's Hospital (US)
• Beth Israel Deaconess Medical Center (US)
• NHS Lothian (GB)
• Harvard University (US)
• Johns Hopkins University (US)
• Emory University (US)
• University of Calgary (CA)
• SUNY Upstate Medical University (US)
• University of Cambridge (GB)
• Johns Hopkins Medicine (US)
• The Royal Free Hospital (GB)
• Massachusetts General Hospital (US)
• Dana-Farber Cancer Institute (US)
• Dana-Farber/Harvard Cancer Center (US)
• Dana-Farber Brigham Cancer Center (US)
• Sidney Kimmel Comprehensive Cancer Center (US)
• Indiana University Melvin and Bren Simon Comprehensive Cancer Center
• University College London (GB)
• Indiana University – Purdue University Indianapolis (US)
• University of Pennsylvania (US)

Publication Details

Journal

Journal of Clinical Oncology

Published

2026-05-27

DOI

https://doi.org/10.1200/jco.2026.44.16_suppl.4540

Primary Topic

Renal cell carcinoma treatment

Type

article

Field-Weighted Citation Impact

0.00

Funders

• ECOG-ACRIN Cancer Research Group